Hospital Mater Dei S.A. (BVMF:MATD3)
Brazil · Delayed Price · Currency is BRL 5.76
+0.01 (0.17%)
Last updated: Apr 2, 2026, 4:13 PM GMT-3
Hospital Mater Dei Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,139 | 2,226 | 2,188 | 1,763 | 1,024 |
Other Revenue | 36.31 | - | - | - | - |
| 2,175 | 2,226 | 2,188 | 1,763 | 1,024 | |
Revenue Growth (YoY) | -2.28% | 1.75% | 24.08% | 72.13% | 42.69% |
Cost of Revenue | 1,434 | 1,555 | 1,476 | 1,140 | 619.65 |
Gross Profit | 741.29 | 670.6 | 711.85 | 623.19 | 404.66 |
Selling, General & Admin | 255.69 | 298.71 | 296.29 | 269.09 | 134.12 |
Other Operating Expenses | 19.26 | 25.49 | 10.98 | 9.65 | 13.68 |
Operating Expenses | 386.06 | 324.2 | 307.27 | 278.74 | 147.8 |
Operating Income | 355.23 | 346.4 | 404.58 | 344.45 | 256.86 |
Interest Expense | -302.3 | -233.94 | -243.84 | -224.64 | -80.52 |
Interest & Investment Income | 115.63 | 40.45 | 31.07 | 70.61 | 56.62 |
Earnings From Equity Investments | -1.51 | -2.43 | 2.66 | -0.29 | 0.08 |
Currency Exchange Gain (Loss) | - | -1.28 | -0.02 | -1.48 | 1.58 |
Other Non Operating Income (Expenses) | 0.03 | 32.01 | -2.03 | 3.44 | 0.53 |
EBT Excluding Unusual Items | 167.09 | 181.2 | 192.42 | 192.09 | 235.16 |
Gain (Loss) on Sale of Investments | - | -754.26 | - | - | - |
Legal Settlements | - | 74.45 | 16.38 | -6.26 | -14.68 |
Pretax Income | 167.09 | -498.61 | 208.79 | 185.83 | 220.48 |
Income Tax Expense | 55.17 | -174.71 | 67.55 | 63.15 | 73.63 |
Earnings From Continuing Operations | 111.92 | -323.9 | 141.25 | 122.69 | 146.85 |
Minority Interest in Earnings | - | -14.54 | -21.59 | -19.18 | -1.93 |
Net Income | 111.92 | -338.44 | 119.65 | 103.51 | 144.92 |
Net Income to Common | 111.92 | -338.44 | 119.65 | 103.51 | 144.92 |
Net Income Growth | - | - | 15.60% | -28.58% | 99.50% |
Shares Outstanding (Basic) | 333 | 375 | 382 | 382 | 304 |
Shares Outstanding (Diluted) | 333 | 375 | 404 | 409 | 331 |
Shares Change (YoY) | -11.14% | -7.18% | -1.30% | 23.74% | -1.65% |
EPS (Basic) | 0.34 | -0.90 | 0.31 | 0.27 | 0.48 |
EPS (Diluted) | 0.34 | -0.90 | 0.30 | 0.25 | 0.44 |
EPS Growth | - | - | 20.00% | -43.18% | 103.61% |
Free Cash Flow | 176.76 | -69.36 | -25.54 | -231.91 | -182.63 |
Free Cash Flow Per Share | 0.53 | -0.18 | -0.06 | -0.57 | -0.55 |
Dividend Per Share | 0.151 | 0.075 | 0.070 | 0.064 | 0.090 |
Dividend Growth | 101.07% | 6.94% | 9.38% | -28.89% | -40.00% |
Gross Margin | 34.08% | 30.13% | 32.54% | 35.34% | 39.51% |
Operating Margin | 16.33% | 15.56% | 18.49% | 19.54% | 25.08% |
Profit Margin | 5.15% | -15.20% | 5.47% | 5.87% | 14.15% |
Free Cash Flow Margin | 8.13% | -3.12% | -1.17% | -13.15% | -17.83% |
EBITDA | 466.34 | 416.1 | 467.33 | 400.43 | 277.22 |
EBITDA Margin | 21.44% | 18.69% | 21.36% | 22.71% | 27.06% |
D&A For EBITDA | 111.11 | 69.71 | 62.75 | 55.99 | 20.35 |
EBIT | 355.23 | 346.4 | 404.58 | 344.45 | 256.86 |
EBIT Margin | 16.33% | 15.56% | 18.49% | 19.54% | 25.08% |
Effective Tax Rate | 33.02% | - | 32.35% | 33.98% | 33.40% |
Revenue as Reported | 2,175 | - | - | - | - |
Advertising Expenses | - | 3.39 | 2.71 | 4.8 | 2.13 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.